Detection of Cerebral Ischemia With Artificial Intelligence.

NCT03919370 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2026-02-06

No results posted yet for this study

Summary

In patients undergoing planned surgery for carotid tromendarterendectomy, a non-invasive device that registers heart rate variability is attached. Furthermore a non-invasive device that monitors cerebral oxygenation- near infrared spectroscopy as well as electroencephalography is also attached. At times when surgeons clamps the carotid artery, there will be a moment with controlled cerebral ischemia.

This will be registered by the devices. The information obtained will be used to teach artificial intelligence what patterns are related to cerebral ischemia. The same procedure will be performed in patients undergoing ocklusive cerebral trombectomy, so the artificial intelligence will learn to recognize cerebral reperfusion.Blood samples will be drawn before and after cerebral ischemia may occur and will be analyzed for neurobiomarkers and cardiac biomarkers. To teach the algorithm patterns from anaesthesia and surgery in patients without pre existing neuronal injury, the same method will be applied to patients undergoing mixed abdominal surgery. This group will provide a better knowledge of neuro biomarker patterns during anesthesia and surgery.

Conditions

  • Ischemia, Cerebral
  • Ischemic Stroke
  • Artery Occlusion
  • Artery Carotid Stenosi
  • Anesthesia
  • Surgery

Interventions

OTHER

No intervention

there will be NO intervention

Sponsors & Collaborators

  • Linda Block

    lead OTHER
  • Göteborg University

    collaborator OTHER

Principal Investigators

  • Linda Block, PhD · Inst Clin Sciences

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-10-01
Primary Completion
2024-12-31
Completion
2024-12-31

Countries

  • Sweden

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03919370 on ClinicalTrials.gov